In patients with LEAD, intravascular ultrasound guidance is associated with improved outcomes following endovascular treatment.
Groundbreaking findings from the landmark CLEAR (Clinical trial Comparing Lenvatinib with Ecerolimus or Pembrolizumab in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results